Skip to content

Application of Virtual Reality for the Reduction of Postoperative Pain and Analgesic Use in Visceral-Oncological Patients

Application of Virtual Reality for the Reduction of Postoperative Pain and Analgesic Use in Visceral-Oncological Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00037140
Enrollment
150
Registered
2025-06-10
Start date
2026-07-22
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain "ICD-10 G89. 18" (ICD-10-CM)

Interventions

Group 1: In the intervention group, a virtual reality headset (Meta Quest 3) will be used to play a 20-minute sequence on the 1st, 2nd, and 3rd postoperative day in the late afternoon. This measure is

Sponsors

Universitätsklinikum Hambrug-Eppendorf
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Conventional visceral-oncological procedures involving the abdomen, including stomach, duodenum, small intestine, colon, rectum, liver, gallbladder, pancreas, and spleen - Age equal to or greater than 18 years - Patient’s ability to understand the study content and procedures and actively participate in the study - Planned hospital stay of at least 5 days

Exclusion criteria

Exclusion criteria: - Epilepsy - Obesity grade 3 or higher - Chronic pain syndrome - Cognitive impairment - Severe anxiety or panic disorders - Uncontrolled visual or auditory disorders - Palliative oncological resections - Known drug or alcohol abuse - Minimally invasive surgical procedures - Participation in other studies that could influence the outcomes or add additional burden - Presence of an abdominal VAC system - Prolonged ICU stay > 1 day

Design outcomes

Primary

MeasureTime frame
Reduction of postoperative pain intensity, measured using the Numerical Rating Scale (NRS).

Secondary

MeasureTime frame
Reduction in analgesic consumption, particularly opioids, through VR intervention. Evaluation of anxiety and stress reduction via VR, assessed with standardized scales - State-Trait Anxiety Inventory (STAI-6) questionnaire. Analysis of recovery quality using the Quality of-Recovery-15 questionnaire. Assessment of effects on mortality and morbidity, evaluated according to the Clavien-Dindo classification.

Countries

Germany

Contacts

Public ContactAnna Nießen

Universitätsklinikum Hamburg-Eppendorf

an.niessen@uke.de+4915228842074

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026